房颤导管消融手术相关并发症的系统综述与汇总分析
该系统综述与汇总分析检索2013至2022年随机对照试验,纳入89项研究共15701例首次接受射频或冷冻球囊房颤消融的患者。总体和严重手术相关并发症发生率分别为4.51%和2.44%,血管并发症最常见(1.31%);近5年发表研究的并发症率显著低于前5年(3.77% vs 5.31%,P=0.043),死亡率保持稳定。
要点
- 房颤导管消融总体并发症率4.51%,严重并发症率2.44%。
- 血管并发症最常见(1.31%),其中心包积液/填塞0.78%,卒中/TIA 0.17%。
- 近5年并发症率较前5年显著下降(3.77% vs 5.31%,P=0.043),死亡率无差异。
核心结论
- 房颤导管消融的手术相关并发症和死亡率较低,且在过去十年中呈下降趋势。
研究设计与样本
- 系统综述与汇总分析,检索MEDLINE和EMBASE从2013年1月至2022年9月的随机对照试验(PROSPERO注册号CRD42022370273)。
- 共检索到1468篇文献,纳入89项研究,合计15701例首次接受射频或冷冻球囊房颤消融的患者。
主要发现
- 总体手术相关并发症发生率为4.51%(95%CI:3.76%-5.32%),严重并发症发生率为2.44%(95%CI:1.98%-2.93%)。
- 血管并发症最常见,发生率为1.31%;其次为心包积液/填塞(0.78%)和卒中/短暂性脑缺血发作(0.17%)。
- 近5年发表研究的并发症发生率显著低于前5年(3.77% vs 5.31%;P=0.043)。
- 两个时间段的汇总死亡率保持稳定(0.06% vs 0.05%;P=0.892)。
- 并发症发生率根据房颤类型、消融方式或肺静脉隔离以外的消融策略无显著差异。
临床怎么用
- 房颤导管消融的整体并发症风险较低,可作为临床决策和患者沟通的参考依据。
- 应关注血管并发症和心包积液/填塞的预防与早期识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Catheter ablation of atrial fibrillation (AF) is a commonly performed procedure. However, it is associated with potentially significant complications. Reported procedure-related complication rates are highly variable, depending in part on study design. OBJECTIVES: The purpose of this systematic review and pooled analysis was to determine the rate of procedure-related complications associated with catheter ablation of AF using data from randomized control trials and to assess temporal trends. METHODS: MEDLINE and EMBASE databases were searched from January 2013 to September 2022 for randomized control trials that included patients undergoing a first ablation procedure of AF using either radiofrequency or cryoballoon (PROSPERO, CRD42022370273). RESULTS: A total of 1,468 references were retrieved, of which 89 studies met inclusion criteria. A total of 15,701 patients were included in the current analysis. Overall and severe procedure-related complication rates were 4.51% (95% CI: 3.76%-5.32%) and 2.44% (95% CI: 1.98%-2.93%), respectively. Vascular complications were the most frequent type of complication (1.31%). The next most common complications were pericardial effusion/tamponade (0.78%) and stroke/transient ischemic attack (0.17%). The procedure-related complication rate during the most recent 5-year period of publication was significantly lower than during the earlier 5-year period (3.77% vs 5.31%; P = 0.043). The pooled mortality rate was stable over the 2 time periods (0.06% vs 0.05%; P = 0.892). There was no significant difference in complication rate according to pattern of AF, ablation modality, or ablation strategies beyond pulmonary vein isolation. CONCLUSIONS: Procedure-related complications and mortality rates associated with catheter ablation of AF are low and have declined in the past decade.
引用
- Benali, Khairy, Hammache, et al. Procedure-Related Complications of Catheter Ablation for Atrial Fibrillation. J Am Coll Cardiol. 2023. PMID: 37225362. doi:10.1016/j.jacc.2023.03.418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。